Spironolactone and Hydrochlorothiazide (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Spironolactone and Hydrochlorothiazide drug offered from Mylan Pharmaceuticals Inc.. This Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | spironolactone and hydrochlorothiazide |
| SUBSTANCE NAME: | SPIRONOLACTONE; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-07-26 |
| END MARKETING DATE: | 2020-02-29 |
Spironolactone and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Spironolactone and Hydrochlorothiazide from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25; 25(mg/1; mg/1) |
| START MARKETING DATE: | 2012-07-26 |
| END MARKETING DATE: | 2020-02-29 |
| PRODUCT ID: | 0378-0141_c1a7f6b1-1c3c-4e35-bcb5-b97c0a9e6454 |
| PRODUCT NDC: | 0378-0141 |
| APPLICATION NUMBER: | ANDA086513 |
Other SPIRONOLACTONE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
